TGF-β is also capable of facilitating immune escape by inhibiting NKG2D (an activating receptor responsible for host-response to pathogen and tumor cells) on CD8+ T cells and NK cells ultimately rendering the cells less effective at cytotoxic destruction of GBM (83). The gene discussed is CD8A; the disease is glioblastoma.